134 related articles for article (PubMed ID: 1326404)
1. Sumatriptan injection is superior to placebo in the acute treatment of migraine--with regard to both efficacy and general well-being.
Dahlöf C; Edwards C; Toth A
Cephalalgia; 1992 Aug; 12(4):214-20. PubMed ID: 1326404
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group.
Bousser MG; D'Allens H; Richard A
J Intern Med; 1993 Aug; 234(2):211-6. PubMed ID: 8393474
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.
Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA
N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute migraine with subcutaneous sumatriptan.
Cady RK; Wendt JK; Kirchner JR; Sargent JD; Rothrock JF; Skaggs H
JAMA; 1991 Jun; 265(21):2831-5. PubMed ID: 1851894
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous sumatriptan in the acute treatment of migraine. Sumatriptan International Study Group.
Ensink FB
J Neurol; 1991; 238 Suppl 1():S66-9. PubMed ID: 1646291
[TBL] [Abstract][Full Text] [Related]
6. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
Eur Neurol; 1991; 31(5):323-31. PubMed ID: 1653140
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
8. Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group.
Eur Neurol; 1991; 31(5):300-5. PubMed ID: 1653137
[TBL] [Abstract][Full Text] [Related]
9. Oral sumatriptan in acute migraine.
Goadsby PJ; Zagami AS; Donnan GA; Symington G; Anthony M; Bladin PF; Lance JW
Lancet; 1991 Sep; 338(8770):782-3. PubMed ID: 1681162
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of subcutaneous sumatriptan in repeated episodes of migraine.
Cady RK; Dexter J; Sargent JD; Markley H; Osterhaus JT; Webster CJ
Neurology; 1993 Jul; 43(7):1363-8. PubMed ID: 8392150
[TBL] [Abstract][Full Text] [Related]
11. Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group.
Visser WH; Ferrari MD; Bayliss EM; Ludlow S; Pilgrim AJ
Cephalalgia; 1992 Oct; 12(5):308-13. PubMed ID: 1330318
[TBL] [Abstract][Full Text] [Related]
12. Initial clinical experience with the use of subcutaneous GR43175 in treating acute migraine.
Brion N; Bons J; Plas J; Bayliss EM; Advenier C
Cephalalgia; 1989; 9 Suppl 9():79-82. PubMed ID: 2544288
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group.
Eur Neurol; 1991; 31(5):314-22. PubMed ID: 1653139
[TBL] [Abstract][Full Text] [Related]
14. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute migraine with subcutaneous GR43175 in West Germany.
Baar HA; Brand J; Doenicke A; Melchart D; Lüben V; Tryba M; Sahlender HM
Cephalalgia; 1989; 9 Suppl 9():83-7. PubMed ID: 2544289
[TBL] [Abstract][Full Text] [Related]
16. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group.
Eur Neurol; 1992; 32(3):177-84. PubMed ID: 1317294
[TBL] [Abstract][Full Text] [Related]
17. Sumatriptan in acute migraine using a novel cartridge system self-injector. United Kingdom Study Group.
Gross ML; Kay J; Turner AM; Hallett K; Cleal AL; Hassani H
Headache; 1994; 34(10):559-63. PubMed ID: 7843948
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. The Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group.
Eur Neurol; 1991; 31(5):332-8. PubMed ID: 1653141
[TBL] [Abstract][Full Text] [Related]
19. Treatment of migraine attacks with sumatriptan.
Subcutaneous Sumatriptan International Study Group
N Engl J Med; 1991 Aug; 325(5):316-21. PubMed ID: 1647495
[TBL] [Abstract][Full Text] [Related]
20. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
